MedPath

Study of injection methylene blue after surgery around anus for decreasing pai

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/09/057852
Lead Sponsor
Dr Pratik Jadhav
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing perianal surgery,who are willing to participate in the study and will give written informed consent.

Exclusion Criteria

1)Patient allergic to methylene blue.

2)Patients with immune compromised status.

3)Patients on anticoagulant therapy.

4)Patients who underwent repeated perianal surgery.

5)Patients with skin infection (fungal infections etc).

6)Diabetes mellitus, neuropathy, trauma,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess use of pain relief of Methylene blue by assessing pain score on visual analogue scale (VAS scale)at 4,8,12,24 hours interval for 5 days postoperativelyTimepoint: At 4,8,12,24 hours interval for 5 days post operatively <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes will be noted like skin edema, Staining of skin, Local pain, Dizziness, fever, redness, local rise in temperature etcTimepoint: At 4,8,12,24 hours interval for 5 days post operatively
© Copyright 2025. All Rights Reserved by MedPath